company background image
1612

Vincent Medical HoldingsSEHK:1612 Stock Report

Last Price

HK$0.94

Market Cap

HK$614.7m

7D

-1.1%

1Y

-59.5%

Updated

22 Jan, 2022

Data

Company Financials +
1612 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance6/6
Financial Health5/6
Dividends3/6

1612 Stock Overview

Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices.

Vincent Medical Holdings Competitors

Koninklijke Philips

ENXTAM:PHIA

€25.2b

Teleflex

NYSE:TFX

US$15.1b

Fisher & Paykel Healthcare

NZSE:FPH

NZ$16.9b

Shandong Weigao Group Medical Polymer

SEHK:1066

HK$45.0b

Price History & Performance

Summary of all time highs, changes and price drops for Vincent Medical Holdings
Historical stock prices
Current Share PriceHK$0.94
52 Week HighHK$2.69
52 Week LowHK$0.84
Beta-0.39
1 Month Change-7.84%
3 Month Change2.17%
1 Year Change-59.48%
3 Year Change56.67%
5 Year Change-14.55%
Change since IPO0%

Recent News & Updates

Shareholder Returns

1612HK Medical EquipmentHK Market
7D-1.1%-1.1%1.9%
1Y-59.5%-44.0%-13.4%

Return vs Industry: 1612 underperformed the Hong Kong Medical Equipment industry which returned -44% over the past year.

Return vs Market: 1612 underperformed the Hong Kong Market which returned -13.4% over the past year.

Price Volatility

Is 1612's price volatile compared to industry and market?
1612 volatility
1612 Average Weekly Movement12.2%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.7%
10% most volatile stocks in HK Market13.1%
10% least volatile stocks in HK Market3.1%

Stable Share Price: 1612 is more volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: 1612's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
19971,390To Ki Cheunghttps://www.vincentmedical.com

Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. It operates in two segments, Original Equipment Manufacturing (OEM) and Original Brand Manufacturing. The company develops medical devices focusing on respiratory products; imaging contrast media power injector disposables; and orthopedic and rehabilitation products for OEM customers.

Vincent Medical Holdings Fundamentals Summary

How do Vincent Medical Holdings's earnings and revenue compare to its market cap?
1612 fundamental statistics
Market CapHK$614.71m
Earnings (TTM)HK$166.88m
Revenue (TTM)HK$1.02b

3.7x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
1612 income statement (TTM)
RevenueHK$1.02b
Cost of RevenueHK$629.12m
Gross ProfitHK$394.62m
ExpensesHK$227.74m
EarningsHK$166.88m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.26
Gross Margin38.55%
Net Profit Margin16.30%
Debt/Equity Ratio11.6%

How did 1612 perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

50%

Payout Ratio

Valuation

Is Vincent Medical Holdings undervalued compared to its fair value and its price relative to the market?

1.0%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 1612 (HK$0.94) is trading below our estimate of fair value (HK$0.95)

Significantly Below Fair Value: 1612 is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: 1612 is good value based on its PE Ratio (3.7x) compared to the Hong Kong Medical Equipment industry average (21.7x).

PE vs Market: 1612 is good value based on its PE Ratio (3.7x) compared to the Hong Kong market (9.1x).


Price to Earnings Growth Ratio

PEG Ratio: 1612's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: 1612 is good value based on its PB Ratio (1x) compared to the HK Medical Equipment industry average (2.3x).


Future Growth

How is Vincent Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

-16.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1612's earnings are forecast to decline over the next 3 years (-16.9% per year).

Earnings vs Market: 1612's earnings are forecast to decline over the next 3 years (-16.9% per year).

High Growth Earnings: 1612's earnings are forecast to decline over the next 3 years.

Revenue vs Market: 1612's revenue (3.3% per year) is forecast to grow slower than the Hong Kong market (11.6% per year).

High Growth Revenue: 1612's revenue (3.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1612's Return on Equity is forecast to be low in 3 years time (13.2%).


Past Performance

How has Vincent Medical Holdings performed over the past 5 years?

47.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 1612 has high quality earnings.

Growing Profit Margin: 1612's current net profit margins (16.3%) are higher than last year (11.8%).


Past Earnings Growth Analysis

Earnings Trend: 1612's earnings have grown significantly by 47.8% per year over the past 5 years.

Accelerating Growth: 1612's earnings growth over the past year (86%) exceeds its 5-year average (47.8% per year).

Earnings vs Industry: 1612 earnings growth over the past year (86%) exceeded the Medical Equipment industry 50.4%.


Return on Equity

High ROE: 1612's Return on Equity (30.4%) is considered high.


Financial Health

How is Vincent Medical Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 1612's short term assets (HK$656.0M) exceed its short term liabilities (HK$284.5M).

Long Term Liabilities: 1612's short term assets (HK$656.0M) exceed its long term liabilities (HK$11.7M).


Debt to Equity History and Analysis

Debt Level: 1612 has more cash than its total debt.

Reducing Debt: 1612's debt to equity ratio has increased from 3.8% to 11.6% over the past 5 years.

Debt Coverage: 1612's debt is well covered by operating cash flow (233.5%).

Interest Coverage: 1612's interest payments on its debt are well covered by EBIT (73.4x coverage).


Balance Sheet


Dividend

What is Vincent Medical Holdings's current dividend yield, its reliability and sustainability?

4.26%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 1612's dividend (4.26%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.31%).

High Dividend: 1612's dividend (4.26%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.95%).


Stability and Growth of Payments

Stable Dividend: 1612 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 1612's dividend payments have increased, but the company has only paid a dividend for 5 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (50.5%), 1612's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: 1612's dividends in 3 years are forecast to be well covered by earnings (30.9% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.7yrs

Average board tenure


CEO

To Ki Cheung (54 yo)

no data

Tenure

HK$2,778,000

Compensation

Mr. To Ki Cheung serves as Director at Inovytec Medical Solutions Ltd. He serves as Chief Executive Officer and General Manager at Vincent Medical Holdings Limited and has been its Executive Director Novem...


CEO Compensation Analysis

Compensation vs Market: To Ki's total compensation ($USD356.79K) is above average for companies of similar size in the Hong Kong market ($USD233.49K).

Compensation vs Earnings: To Ki's compensation has increased by more than 20% in the past year.


Board Members

Experienced Board: 1612's board of directors are considered experienced (5.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: 1612 insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Vincent Medical Holdings Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Vincent Medical Holdings Limited
  • Ticker: 1612
  • Exchange: SEHK
  • Founded: 1997
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: HK$614.710m
  • Shares outstanding: 653.95m
  • Website: https://www.vincentmedical.com

Number of Employees


Location

  • Vincent Medical Holdings Limited
  • Hang Fung Industrial Building
  • Flat B2, 7th Floor, Phase 2
  • Hung Hom
  • Kowloon
  • Hong Kong

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/22 10:02
End of Day Share Price2022/01/21 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.